Mohammadreza Hajiesmaeili
Overview
Explore the profile of Mohammadreza Hajiesmaeili including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
52
Citations
629
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Sakhaee F, Mafi S, Zargar M, Vaziri F, Hajiesmaeili M, Siadat S, et al.
Environ Sci Pollut Res Int
. 2022 Jan;
29(27):41368-41374.
PMID: 35089517
Legionella pneumophila (L. pneumophila) is one of the main pathogens, causing pneumonia and respiratory tract infections, especially in patients with ventilator-associated pneumonia (VAP). This study aimed to approve the hypothesis...
22.
Hussen B, Salihi A, Abdullah S, Rasul M, Hidayat H, Hajiesmaeili M, et al.
Pathol Res Pract
. 2022 Jan;
230:153764.
PMID: 35032831
MicroRNAs (miRNAs) act as oncogenes or tumor suppressors by suppressing the expression of target genes, some of which are engaged in angiogenic signaling pathways directly or indirectly. Tumor development and...
23.
Alavi Darazam I, Besharati S, Shabani M, Shokouhi S, Fallahzadeh M, Shabanpour Dehbsneh H, et al.
Tanaffos
. 2022 Jan;
20(2):156-163.
PMID: 34976087
Background: Coronavirus disease 2019 (COVID-19) has been pandemic and has caused a great burden on almost all countries across the world. Different perspectives of this novel disease are poorly understood....
24.
Fathi M, Vakili K, Jazi K, Sadeghi M, Hajiesmaeili M, Mohamadkhani A, et al.
Tumori
. 2021 Dec;
108(5):407-419.
PMID: 34918602
People at high risk of morbidity and mortality from coronavirus disease 2019 (COVID-19), including patients dealing with malignancies and patients on immunosuppressive anticancer therapies, need to be followed carefully as...
25.
Fallahzadeh M, Pourhoseingholi M, Boroujeni M, Besharati S, Mardani M, Shabani M, et al.
J Med Virol
. 2021 Nov;
94(4):1488-1493.
PMID: 34821387
Interferons are an essential part of the innate immune system and have antiviral and immunomodulatory functions. We studied the effects of interferon β-1a on the outcomes of severe cases of...
26.
Ghafouri-Fard S, Khoshbakht T, Taheri M, Hajiesmaeili M
Pathol Res Pract
. 2021 Aug;
225:153556.
PMID: 34391180
Long intergenic non-coding RNAs (lincRNAs) establish a group of long non-coding RNAs (lncRNAs) that have no overlap with protein-coding genes. These transcripts have been found to affect chromatin configurations, arrange...
27.
Shabani M, Totonchi M, Rezaeimirghaed O, Gachkar L, Hajiesmaeili M, Khoshkar A, et al.
Pulm Pharmacol Ther
. 2021 Aug;
70:102069.
PMID: 34389507
Introduction: The coronavirus disease 2019 (COVID-19) pandemic has caused significant mortality worldwide. The disease attacks the lung tissue and may lead to acute respiratory distress syndrome. An in vitro study...
28.
Ghafouri-Fard S, Hajiesmaeili M, Shoorei H, Bahroudi Z, Taheri M, Sharifi G
Front Cell Dev Biol
. 2021 Aug;
9:696820.
PMID: 34368145
Stem cells have two important features, namely the ability for self-renewal and the capacity to differentiate into some cell kinds with specialized functions. These two features are also present in...
29.
Alavi Darazam I, Shokouhi S, Mardani M, Pourhoseingholi M, Rabiei M, Hatami F, et al.
Int Immunopharmacol
. 2021 Jul;
99:107969.
PMID: 34273635
Introduction: The effectiveness of umifenovir against COVID-19 is controversial; therefore, clinical trials are crucial to evaluate its efficacy. Methods: The study was conducted as a single-center, randomized, open-label clinical trial....
30.
Alavi Darazam I, Hatami F, Rabiei M, Pourhoseingholi M, Shabani M, Shokouhi S, et al.
Int Immunopharmacol
. 2021 Jul;
99:107916.
PMID: 34224994
Introduction: Coronavirus disease 2019 (COVID-19) has been a serious obstacle in front of public health. Interferon-beta 1a (IFN-β 1a) has been used to treat patients with COVID-19. We aimed to...